3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Burkitt Lymphoma
8
Leukemia, Biphenotypic, Acute
5
Leukemia, Myeloid, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Hydatidiform Mole
2
Down Syndrome
2
Urinary Bladder Neoplasms
1
Rhabdoid Tumor
1
Osteosarcoma
1
Myeloproliferative Syndrome, Transient
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Graft vs Host Disease
1
Congenital Abnormalities
1
Chromosome 5q Deletion Syndrome
1
Choriocarcinoma
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Refractory
1
Interventions
Methotrexate
4
Doxorubicin
3
Ifosfamide
2
Etoposide
2
Cisplatin
2
sodium thiosulfate
1
peginterferon alfa-2b
1
merphos
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Specimen Handling
1
Sodium Chloride
1
Restraint, Physical
1
Platinum
1
IMVP-16 protocol
1
Granulocyte Colony-Stimulating Factor
1
Fluoridation
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cyproheptadine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Osteosarcoma
×
merphos
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts